SB 426 Oklahoma Senate · 2026 Regular Session

Practice of pharmacy; designating certain drugs as over-the-counter; prohibiting pharmacist or pharmacy from requiring prescription; providing penalties. Effective date.

SB 426 designates chloroquine, hydroxychloroquine, and ivermectin as over-the-counter drugs in Oklahoma, requiring pharmacists and pharmacies to sell these medications without prescriptions. The bill directly affects pharmacists and pharmacies, prohibiting them from demanding prescriptions for these specific drugs. Violations carry severe penalties: license revocation and a $100,000 fine per occurrence, enforced by the State Board of Pharmacy. This law creates a concrete policy change by removing prescription barriers for these three medications at the point of sale.
Bill status in committee 1 of 4 stages cleared
Introduction
Feb 2025
Committee Review
Floor Vote
Governor
Introduced Feb 3, 2025 Last action Feb 20, 2025
Floor votes

How they voted

No floor votes recorded yet.
Full legislative history

Actions timeline

Total actions
4
Key actions
0
Committee
0
Feb 3, 2025
Introduced
First Reading
upper
1 primary · 0 co-sponsors

Sponsors

Role
Legislator
Party
State
District
P
Photo of Shane Jett
Shane Jett
RRepublican
OK
17